DNLI FY 2025 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

DNLIDenali Therapeutics Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$11M

Operating Income

-$555M

Net Income

-$513M

EPS (Diluted)

$-2.97

Cash Flow

Operating Cash Flow

-$413M

Free Cash Flow

-$422M

Stock-Based Comp.

$100M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$131M

Stockholders' Equity

$1.0B

Cash & Equivalents

$205M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$11M	$0	—
Operating Income	-$555M	-$487M	-14.0%
Net Income	-$513M	-$423M	-21.2%